טוען...
Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals
Protease inhibitors are key components in the chemotherapy of HIV infection. However, the appearance of viral mutants routinely compromises their clinical efficacy, creating a constant need for new and more potent inhibitors. Recently, a new class of epoxide-based inhibitors of HIV-1 protease was in...
שמור ב:
| הוצא לאור ב: | Molecules |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6273989/ https://ncbi.nlm.nih.gov/pubmed/27809253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules21111458 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|